XML 47 R36.htm IDEA: XBRL DOCUMENT v3.7.0.1
Revenue Recognition (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
Jun. 30, 2016
Revenue Recognition [Line Items]          
Revenue, Net, Total $ 894,000 $ 647,000 $ 2,386,000 $ 1,561,000  
Deferred Revenue         $ 426,000
License and Maintenance Revenue 0 $ 21,000 0 $ 64,000  
KOREA, REPUBLIC OF | Korean Pharmaceutical Company [Member]          
Revenue Recognition [Line Items]          
Deferred Revenue 500,000   500,000    
CANADA | Canadian Based Supplier [Member]          
Revenue Recognition [Line Items]          
Deferred Revenue $ 250,000   $ 250,000